Published in Acta Oncol on January 01, 2000
I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environ Health Perspect (2011) 2.95
How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies. Curr Opin Endocrinol Diabetes Obes (2014) 0.85
Preoperative determination of serum thyroglobulin to identify patients with differentiated thyroid cancer who may present recurrence without increased thyroglobulin. Acta Otorhinolaryngol Ital (2005) 0.81
Biomarkers of thyroid function and autoimmunity for predicting high-risk groups of thyroid cancer: a nested case-control study. BMC Cancer (2014) 0.79
Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics. Biomed Res Int (2015) 0.77
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet (1996) 4.38
Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet (1998) 3.61
Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer (1990) 2.61
Fifteen percent of myocardial infarctions and coronary revascularizations explained by family history unrelated to conventional risk factors. The Reykjavik Cohort Study. Eur Heart J (2002) 2.60
Screening for cancer of the uterine cervix in Iceland 1965--1978. Acta Obstet Gynecol Scand (1982) 2.57
Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer (1977) 2.56
Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol (2001) 2.48
Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. BMJ (1992) 2.39
Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet (1997) 2.28
Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study. Ann Intern Med (1995) 2.14
Incidence and prevalence of recognised and unrecognised myocardial infarction in women. The Reykjavik Study. Eur Heart J (1998) 1.99
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet (2005) 1.91
Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Haematology and Oncology. N Engl J Med (1998) 1.87
Decline in ischaemic heart disease in Iceland and change in risk factor levels. BMJ (1991) 1.86
Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control (2001) 1.82
Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev (1997) 1.80
Incidence of cancer among commercial airline pilots. Occup Environ Med (2000) 1.79
Low iron-binding capacity as a risk factor for myocardial infarction. Circulation (1994) 1.68
Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries. Acta Pathol Microbiol Immunol Scand Suppl (1986) 1.60
Breastfeeding and reduced risk of breast cancer in an Icelandic cohort study. Am J Epidemiol (2001) 1.59
High incidence of classical Kaposi's sarcoma in Iceland and the Faroe Islands. Br J Cancer (1998) 1.45
Oral contraceptive use at a young age and the risk of breast cancer: an Icelandic, population-based cohort study of the effect of birth year. Br J Cancer (1997) 1.40
Reproductive factors and risk for breast cancer in Iceland. Int J Cancer (1978) 1.39
Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand (1995) 1.38
Epidemiology of breast cancer in families in Iceland. J Med Genet (1992) 1.36
Effects of leisure-time physical activity and ventilatory function on risk for stroke in men: the Reykjavík Study. Ann Intern Med (1999) 1.27
The effect of a single BRCA2 mutation on cancer in Iceland. J Med Genet (2002) 1.26
Breast cancer risk in airline cabin attendants: a nested case-control study in Iceland. Occup Environ Med (2003) 1.21
Linkage to BRCA2 region in hereditary male breast cancer. Lancet (1995) 1.21
Risk factors for cutaneous malignant melanoma among aircrews and a random sample of the population. Occup Environ Med (2003) 1.20
A decline and a halt in mean age at menarche in Iceland. Ann Hum Biol (1994) 1.17
Snoring, hypertension, and the sleep apnea syndrome. An epidemiologic survey of middle-aged women. Chest (1993) 1.15
Altered expression of E-cadherin in breast cancer. patterns, mechanisms and clinical significance. Eur J Cancer (2000) 1.14
Familial breast cancer in Iceland. Int J Cancer (1982) 1.13
Prevalence and incidence of NIDDM in Iceland: evidence for stable incidence among males and females 1967-1991--the Reykjavik Study. Diabet Med (1997) 1.13
Neoplastic diseases in families of breast cancer patients. J Med Genet (1994) 1.11
Prevalence of coronary heart disease in Icelandic men 1968-1986. The Reykjavik Study. Eur Heart J (1993) 1.10
The effect of year of birth on the breast cancer age-incidence curve in Iceland. Int J Cancer (1974) 1.09
Migraine patients have lower systolic but higher diastolic blood pressure compared with controls in a population-based study of 21,537 subjects. The Reykjavik Study. Cephalalgia (2006) 1.09
Familial and sporadic breast cancer cases in Iceland: a comparison related to ABO blood groups and risk of bilateral breast cancer. Int J Cancer (1988) 1.09
Silent ST-T changes in an epidemiologic cohort study--a marker of hypertension or coronary heart disease, or both: the Reykjavik study. J Am Coll Cardiol (1996) 1.08
Prolactin studies in "functionless" pituitary tumours. Br Med J (1975) 1.07
Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic Cancer Registries. APMIS Suppl (1993) 1.07
Relative survival of cancer patients--a comparison between Denmark and the other Nordic countries. Acta Oncol (1998) 1.05
The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer. Cytokine (1998) 1.05
Long-term prognosis of different forms of coronary heart disease: the Reykjavik Study. Int J Epidemiol (1995) 1.05
Cosmic radiation and cancer mortality among airline pilots: results from a European cohort study (ESCAPE). Radiat Environ Biophys (2003) 1.05
Coronary heart disease mortality amongst non-insulin-dependent diabetic subjects in Iceland: the independent effect of diabetes. The Reykjavik Study 17-year follow up. J Intern Med (1998) 1.02
Familial non-medullary thyroid cancer in Iceland. J Med Genet (2001) 1.02
Trends in childhood leukaemia in the Nordic countries in relation to fallout from atmospheric nuclear weapons testing. BMJ (1992) 1.02
Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study. Lancet (2001) 1.01
Tumours in Iceland. 10. Malignant tumours of the female breast. A histological classification, laterality, survival and epidemiological considerations. APMIS (1988) 1.00
Latent thyroid carcinoma in Iceland at autopsy. Pathol Res Pract (1992) 1.00
Male breast cancer in Iceland. Int J Cancer (1996) 0.99
The relationship between educational level and mortality. The Reykjavík Study. J Intern Med (2001) 0.98
Gastric cancer after gastrectomy. Int J Cancer (1988) 0.98
Reproductive factors and breast cancer risk in Iceland. A second cohort study. Int J Cancer (1990) 0.97
Cervical cancer screening in Iceland: a case-control study. IARC Sci Publ (1986) 0.97
Mortality and cancer incidence among marine engineers and machinists in Iceland. Scand J Work Environ Health (1988) 0.96
Outcome of sub-total thyroidectomy for thyrotoxicosis in Iceland and Northeast Scotland. Clin Endocrinol (Oxf) (1977) 0.96
Tumours in Iceland. 9. Malignant tumours of the ovary. A histological classification, epidemiological considerations and survival. Acta Pathol Microbiol Immunol Scand A (1987) 0.95
The epidemiology of right bundle branch block and its association with cardiovascular morbidity--the Reykjavik Study. Eur Heart J (1993) 0.95
Prostate cancer--look to Denmark? J Natl Cancer Inst (1996) 0.93
Papillary thyroid carcinoma in Iceland. A study of the occurrence in families and the coexistence of other primary tumours. Acta Oncol (1989) 0.92
Risk of cancer among relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev (2002) 0.92
Evidence of Brucella infection in marine mammals in the North Atlantic Ocean. Vet Rec (1999) 0.92
The value of screening as an approach to cervical cancer control in Iceland, 1964-1986. Int J Cancer (1989) 0.91
Predominance of aortic calcification as an atherosclerotic manifestation in women: the Reykjavik study. J Clin Epidemiol (1996) 0.90
Breast cancer incidence and familiality in Iceland during 75 years from 1921 to 1995. J Med Genet (1999) 0.90
Role of phosphoinositides in the regulation of endothelial prostacyclin production. Arteriosclerosis (1988) 0.89
Familial risk of prostate cancer in Iceland. BJU Int (2003) 0.89
The association between parathyroid hormone, vitamin D and bone mineral density in 70-year-old Icelandic women. Osteoporos Int (2000) 0.89
Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol (1992) 0.88
A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968-1986: a strong relationship to smoking and serum cholesterol--the Reykjavik Study. J Clin Epidemiol (1994) 0.88
Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells. Br J Cancer (2000) 0.88
Left and right sided breast cancer. Pathol Res Pract (1990) 0.88
Endothelial inositol phosphate generation and prostacyclin production in response to G-protein activation by AlF4-. Biochem J (1989) 0.87
The prevalence and prognosis of third-degree atrioventricular conduction block: the Reykjavik study. J Intern Med (1999) 0.87
Genetic epidemiology of breast cancer: segregation analysis of 389 Icelandic pedigrees. Genet Epidemiol (2000) 0.86
Risk profiles and prognosis of treated and untreated hypertensive men and women in a population-based longitudinal study: the Reykjavik Study. J Hum Hypertens (2004) 0.86
Cholecystectomy and colorectal carcinoma: a total-population historical prospective study. Am J Gastroenterol (1991) 0.85
Gastric carcinomas of intestinal type concur with distant changes in the gastric mucosa. A multicenter study in the Atlantic basin. Anticancer Res (2001) 0.84
Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987. Scand J Urol Nephrol (2006) 0.84
45, X-46, XY chromosome mosaic with features of the Russell-Silver syndrome: a case report with a review of the literature. Dev Med Child Neurol (1972) 0.83
Prognostic role of cardiovascular risk factors for men with cardiomegaly (the Reykjavik Study). Am J Cardiol (1996) 0.83
Risk factors and outcome in ICU-acquired infections. Acta Anaesthesiol Scand (2008) 0.83